Xilio Therapeutics, Inc.
XLONext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for XLO. That does not mean none is planned.
Get an email about XLO's next catalysts
Track Xilio Therapeutics (XLO) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
0 upcoming, 2 past
No catalysts found.
Market Overview
Stock performance and key metrics
XTX501
Metastatic NSCLC - Non-Small Cell Lung Cancer
XTX202
Advanced Solid Tumor
vilastobart (XTX101)
Advanced Solid Tumor
XTX301
Advanced Solid Tumor
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
XTX501 | Phase 2 | Metastatic NSCLC - Non-Small Cell Lung Cancer | - | - |
XTX202 | Phase 2 | Advanced Solid Tumor | - | - |
vilastobart (XTX101) | Phase 2 | Advanced Solid Tumor | - | - |
XTX301 | Phase 2 | Advanced Solid Tumor | - | - |
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Frequently asked questions
What is in Xilio Therapeutics, Inc.'s drug pipeline?β
CatalystAlert tracks 4 drug candidates in Xilio Therapeutics, Inc.'s (XLO) pipeline across Phase 2. Its lead program is vilastobart (XTX101) (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Xilio Therapeutics, Inc.'s next FDA catalyst?β
CatalystAlert tracks every upcoming catalyst for Xilio Therapeutics, Inc. (XLO) β PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings β each confidence-rated as confirmed, estimated or AI-detected.
How do I track XLO biotech catalysts?β
Add XLO to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Xilio Therapeutics, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page β sourced from ClinicalTrials.gov, FDA and SEC filings.
